抗生素暴露与成人隐匿性自身免疫糖尿病及2型糖尿病风险:瑞典ESTRID病例对照研究与挪威HUNT研究结果
基于瑞典ESTRID(LADA 597例、2型糖尿病2065例、对照2386例)和挪威HUNT(82/1279/2050)病例对照研究,未发现诊断前10年内广谱抗生素暴露增加LADA风险;窄谱抗生素在诊断前6-10年暴露与LADA风险升高相关(合并OR 1.39,95%CI 1.01,1.91),主要驱动自瑞典数据;2型糖尿病与抗生素暴露关联证据有限。
要点
- 诊断前1年或1-5年任何抗生素暴露与LADA风险无显著关联(合并OR 1.15,95%CI 0.93,1.41;OR 0.98,95%CI 0.80,1.20)。
- 诊断前6-10年窄谱抗生素暴露与LADA风险升高相关(合并OR 1.39,95%CI 1.01,1.91),主要来自瑞典数据。
- 诊断前1-10年抗生素暴露与2型糖尿病风险升高关联证据有限。
核心结论
- 未发现诊断前10年内广谱抗生素暴露增加LADA风险的证据。
- 窄谱抗生素暴露与LADA风险升高存在一定提示,需进一步研究。
研究设计与样本
- 瑞典ESTRID病例对照研究:LADA 597例、2型糖尿病2065例、按参与时间匹配的对照2386例。
- 挪威HUNT研究嵌套病例对照研究:LADA 82例、2型糖尿病1279例、对照2050例。
- 抗生素 dispensing 数据来自瑞典国家处方药登记和挪威处方数据库,采用条件logistic回归估计多变量校正OR,并用固定效应逆方差加权合并。
主要发现
- 诊断/匹配前1年内任何抗生素暴露(≥1次 vs 0次)与LADA风险无显著关联(合并OR 1.15,95%CI 0.93,1.41)。
- 诊断/匹配前1-5年任何抗生素暴露与LADA风险无显著关联(合并OR 0.98,95%CI 0.80,1.20)。
- LADA诊断前6-10年窄谱抗生素暴露(≥1次 vs 0次)与风险升高相关(合并OR 1.39,95%CI 1.01,1.91),主要驱动自瑞典数据;广谱抗生素无此关联。
- 诊断前1-10年抗生素暴露与2型糖尿病风险升高关联证据有限。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Some studies find an increased risk of type 1 diabetes in children exposed to antibiotics. We investigated if exposure to antibiotics increases the risk of latent autoimmune diabetes in adults (LADA) and type 2 diabetes. METHODS: We used data from a Swedish case-control study (Epidemiological Study of Risk Factors for LADA and Type 2 Diabetes [ESTRID]: LADA, n=597; type 2 diabetes, n=2065; control participants matched on participation time, n=2386) and a case-control study nested within the Norwegian Trøndelag Health Study (HUNT) (n=82/1279/2050). Anatomical Therapeutic Chemical (ATC) codes indicating antibiotic dispensations were retrieved from the Swedish National Prescribed Drug Register and Norwegian Prescription Database. Multivariable adjusted ORs with 95% CIs were estimated by conditional logistic regression and pooled using fixed-effects inverse-variance weighting. RESULTS: We observed no increased risk of LADA with exposure to antibiotics up to 1 year (ORpooled 1.15, 95% CI 0.93, 1.41) or 1-5 years (ORpooled 0.98, 95% CI 0.80, 1.20) prior to diagnosis/matching for one or more vs no dispensation of any type of antibiotic. An increased risk was observed for one or more vs no dispensations of narrow-spectrum antibiotics, but not broad-spectrum antibiotics, 6-10 years prior to LADA diagnosis (ORpooled 1.39, 95% CI 1.01, 1.91), which was driven by the Swedish data. There was little evidence of an increased risk of type 2 diabetes associated with antibiotic exposure 1-10 years prior to diagnosis. CONCLUSIONS/INTERPRETATION: We found no evidence that exposure to broad-spectrum antibiotics up to 10 years prior to diagnosis increases the risk of LADA. There was some indication of increased LADA risk with exposure to narrow-spectrum antibiotics, which warrants further investigation.
引用
- Edstorp J, Rossides M, Ahlqvist E, et al. Exposure to antibiotics and risk of latent autoimmune diabetes in adults and type 2 diabetes: results from a Swedish case-control study (ESTRID) and the Norwegian HUNT study. Diabetologia. 2024. PMID: 39467872. doi:10.1007/s00125-024-06302-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。